Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the time has come to return to that oh-so familiar routine of Zoom calls and deadlines. But you knew this would happen. After all, the world, such as it is, keeps spinning. So time to give it a nudge with a delicious cup of stimulation. Our choice today is pumpkin spice. Please feel free to join us. Meanwhile, here are some tidbits to help you on your journey. We hope you have a smashing day, and please do keep in touch. …

A group of international experts — including, notably, two outgoing Food and Drug Administration vaccine regulators — argues in a new paper against offering Covid-19 vaccine boosters to the general population, STAT tells us. The paper, published in the Lancet, is based on a review of available data about the durability of vaccine protection. The paper is sure to add to debate about whether the White House got ahead of its scientific agencies in outlining plans for general boosters, which the Biden administration had signaled would start rolling out next Monday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment